Table 2.
Dynamics of laboratory values during VAD support
| Control (n = 10) | VAD implant (n = 25) | VAD explant (n = 25) | |
|---|---|---|---|
| White blood cell count (×103/μL) | 5.1 ± 0.3 | 8.7 ± 3.5 | 8.5 ± 4.1 |
| Hematocrit (%) | 40.2 ± 5.7 | 28.2 ± 10.2* | 31.7 ± 4.6 |
| Platelets (×103/μL) | 217 ± 17 | 203 ± 85 | 178 ± 73 |
| Sodium (mEq/L) | 140 ± 12 | 135 ± 4 | 138 ± 4 |
| Blood urea nitrogen (mg/dL) | 18 ± 4 | 33 ± 16* | 25 ± 11 |
| Creatinine (mg/dL) | 1.0 ± 0.2 | 2.5 ± 5.3 | 1.3 ± 0.6 |
| Albumin (mg/dL) | 4.7 ± 0.4 | 3.5 ± 0.5* | 3.7 ± 0.5† |
| Total bilirubin (mg/dL) | 0.6 ± 0.2 | 1.6 ± 1.8 | 1.1 ± 0.9 |
| Direct bilirubin (mg/dL) | 0.1 ± 0.0 | 0.6 ± 1.0 | 0.5 ± 0.5 |
| Aspartate aminotransferase (U/L) | 25 ± 10 | 36 ± 27 | 56 ± 56 |
| Alanine transaminase (U/L) | 25 ± 7 | 29 ± 25 | 25 ± 22 |
| Alkaline phosphatase (U/L) | 72 ± 15 | 89 ± 36 | 76 ± 30 |
*p < 0.05 between implants and controls; † p < 0.05 between explants and controls